6533b839fe1ef96bd12a5732

RESEARCH PRODUCT

Role of cannabinoids in the treatment of tinnitus

A. CavallaroF. MartinesC. CannizzaroG. LavancoA. BrancatoG. CarolloF. PlesciaP. SalvagoE. CannizzaroM. MuciaS. RizzoAlessandro MartiniF. Plescia

subject

Dorsal cochlear nucleuTinnituSettore MED/31 - OtorinolaringoiatriaMedicine (all)CannabinoidCannabinoids; Dorsal cochlear nucleus; Tinnitus; Medicine (all)Settore MED/32 - Audiologia

description

Tinnitus is a frequent symptom in audiological clinical practice characterized by an abnormal noise perceived in one or both ears or in the head, in which a patient has a conscious hearing percept in absence of external sound. Tinnitus might be caused by a homeostatic response of central dorsal cochlear nucleus auditory neurons that makes them hyperactive in compensation to auditory input loss. One hypothesis suggests that tinnitus is a sensory form of epilepsy that involves the cochlear nucleus and the inferior colliculus, which display impairment in the electrical activity in the auditory system. This alteration determines a synaptic plasticity in the dorsal cochlear nucleus that becomes a target for pharmacological compounds able to treat tinnitus. There is no effective drug treatment for tinnitus, but different studies propose the use of cannabinoid receptors agonist for their anti-epileptic activity, although their practical effects are still unclear. In this review, we want to analyze the emerging pharmacological approaches of cannabinoid receptor agonists to the therapy of tinnitus.

http://www.scopus.com/inward/record.url?eid=2-s2.0-84995476873&partnerID=MN8TOARS